Shopping Cart
- Remove All
- Your shopping cart is currently empty
Indinavir is an orally administered, specific HIV protease inhibitor commonly used in combination therapy as part of highly active antiretroviral therapy (HAART) for HIV/AIDS. Indinavir also inhibits the activation of MMP-2 in endothelial cells and exhibits affinity for α7-nAchR and SARS-CoV-2 Mpro.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $67 | In Stock | |
5 mg | $162 | In Stock |
Description | Indinavir is an orally administered, specific HIV protease inhibitor commonly used in combination therapy as part of highly active antiretroviral therapy (HAART) for HIV/AIDS. Indinavir also inhibits the activation of MMP-2 in endothelial cells and exhibits affinity for α7-nAchR and SARS-CoV-2 Mpro. |
In vitro | Method: Peripheral blood mononuclear cells (PBMCs) from healthy and HIV-infected individuals were pretreated with Indinavir at concentrations ranging from 0 to 50 μM for 18 hours, followed by stimulation with anti-CD3 antibody for an additional 48 hours. Result: Indinavir inhibited anti-CD3-induced cell cycle progression in a dose-dependent manner and reduced lymphoproliferative responses in a dose-dependent fashion. [1] |
In vivo | Method: Huh7 and SK-HEP-1 hepatocarcinoma cells were subcutaneously implanted into nude mice. After tumor establishment, Indinavir was administered by oral gavage at a dose of 70 mg/kg once daily for 3 weeks. Result: Compared with the control group, Indinavir delayed the growth of subcutaneously implanted hepatocarcinoma xenografts in nude mice.[2] |
Synonyms | MK639 free base |
Molecular Weight | 613.79 |
Formula | C36H47N5O4 |
Cas No. | 150378-17-9 |
Smiles | N(C([C@H](CC1=CC=CC=C1)C[C@@H](CN2[C@H](C(NC(C)(C)C)=O)CN(CC=3C=CC=NC3)CC2)O)=O)[C@H]4C=5C(C[C@H]4O)=CC=CC5 |
Relative Density. | 1.25 g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (130.34 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.